Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chris Runken

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Occupational and Environmental Medicine|April 22, 2011
Longitudinal change in migraine headache-days and indirect cost consequencesWalter F Stewart, G Craig Wood, Christa Bruce, et al.
Headache|April 11, 2012
The development of a survey to measure completeness of response to migraine therapyCheryl D Coon, Sheri E Fehnel, Kimberly H Davis, et al.
Drugs in Context|May 3, 2024
Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregiversDavid Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|December 5, 2024
Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World DataDaniel N Pfeffer, Rahul Dhakne, Omnya El Massad, et al.
Patient Preference and Adherence|May 24, 2019
Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the USJeffrey T Guptill, M Chris Runken, Michael Eaddy, et al.
Expert Review of Neurotherapeutics|November 28, 2022
Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's diseaseRichard B Lipton, Lauren Podger, Walter F Stewart, et al.
Journal of Alzheimer'S Disease : JAD|March 15, 2024
Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR StudyLauren Podger, Walter F Stewart, Daniel Serrano, et al.
Headache|July 30, 2011
Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescentsSusan A McDonald, Andrew D Hershey, Eric Pearlman, et al.
Headache|April 28, 2011
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomesRoger K Cady, Merle L Diamond, Michael P Diamond, et al.
Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Occupational and Environmental Medicine|April 22, 2011
Longitudinal change in migraine headache-days and indirect cost consequencesWalter F Stewart, G Craig Wood, Christa Bruce, et al.
Headache|April 11, 2012
The development of a survey to measure completeness of response to migraine therapyCheryl D Coon, Sheri E Fehnel, Kimberly H Davis, et al.
Drugs in Context|May 3, 2024
Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregiversDavid Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|December 5, 2024
Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World DataDaniel N Pfeffer, Rahul Dhakne, Omnya El Massad, et al.
Patient Preference and Adherence|May 24, 2019
Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the USJeffrey T Guptill, M Chris Runken, Michael Eaddy, et al.
Expert Review of Neurotherapeutics|November 28, 2022
Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's diseaseRichard B Lipton, Lauren Podger, Walter F Stewart, et al.
Journal of Alzheimer'S Disease : JAD|March 15, 2024
Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR StudyLauren Podger, Walter F Stewart, Daniel Serrano, et al.
Headache|July 30, 2011
Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescentsSusan A McDonald, Andrew D Hershey, Eric Pearlman, et al.
Headache|April 28, 2011
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomesRoger K Cady, Merle L Diamond, Michael P Diamond, et al.
Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.
Pageof 4